The cancer-inhibitory activity by AMPK is achieved through regulating one or multiple AMPK downstream signal target proteins, including mTOR inhibition [30–33], p53/p27 activation [34–37], JNK activation [35, 38–40] and Ulk1-autophagy pathway [41]. Here, TP53 is linked to cancer.